Poseida Therapeutics, Inc. Other Accrued Liabilities, Current
Poseida Therapeutics, Inc. had Other Accrued Liabilities, Current of $4.34 million as of 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Notes › Payables and Accruals
us-gaap:OtherAccruedLiabilitiesCurrent · last filed 2024-11-07
- 2024-09-30: Other Accrued Liabilities, Current $4.34M.
- 2024-06-30: Other Accrued Liabilities, Current $4.30M.
- 2024-03-31: Other Accrued Liabilities, Current $4.47M.
- 2023-12-31: Other Accrued Liabilities, Current $3.40M.
| Period end | Other Accrued Liabilities, Current |
|---|---|
| 2024-09-30 | $4.34M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $4.30M 10-Q · filed 2024-08-05 |
| 2024-03-31 | $4.47M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $3.40M 10-Q · filed 2024-11-07 |
| 2023-09-30 | $3.76M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $4.21M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $4.98M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $3.89M 10-K · filed 2024-03-07 |
| 2022-09-30 | $3.48M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $3.77M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $4.06M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $2.49M 10-K · filed 2023-03-09 |
| 2021-09-30 | $2.79M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $1.97M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $1.93M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $1.84M 10-K · filed 2022-03-10 |
| 2020-09-30 | $2.84M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $4.56M 10-Q · filed 2020-08-20 |
| 2019-12-31 | $1.67M 10-K · filed 2021-03-11 |